FDA moves toward easing restrictions on certain peptides BioPharma Dive Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure FDA Issues Warning Letters Against Online GLP 1 Sellers BioSpace FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida